NEW YORK (GenomeWeb News) – Molecular dermatology company PharmaGenoma said today that it has signed up Svenson Haar Studios to distribute its HairDx subsidiary’s genetic test to predict the likelihood of a common type of hair loss.

Svenson will distribute the HairDx test, which provides a gene-based analysis of the chances that men and women will develop androgenetic alopecia, through a network of 17 centers throughout Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.